EUVIMEDEUVIMED entdecken
Crossref

In Silico and in vitro evaluation of Cucurbitaceae seed lectins as promising prophylactic and therapeutic agents against SARS-CoV-2

Rumana Ahmad, Yusuf Akhter, Varsha, Tanveer Ahamad, Aditi Srivastava, Kusum Yadav, Sahabjada Siddiqui, D Himanshu Reddy, Ankita Gupta, Yashi Nigam, Mohammad Amir Khan, Ishrat Husain und 2 weitere

Glycoconjugate Journal · 2025

DOI: 10.1007/s10719-025-10196-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glycoconjugate Journal, 2025. Verfasst von Rumana Ahmad und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Biochemistry, Era's Lucknow Medical College & Hospital, Era University, Sarfarazganj, Hardoi Road, Lucknow, 226003, UP, India. rumana_ahmad@…. Hauptthemen laut MEDLINE: SARS-CoV-2, Spike Glycoprotein, Coronavirus, Seeds, Plant Lectins. Die Arbeit nennt 117 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Concern over COVID-19 has arisen from continuous mutations in SARS-CoV-2 genome leading to emergence of novel variants. A detailed study and understanding of N-linked glycans (NAGs) of SARS-CoV-2 spike protein are key for the development of vaccines and new therapeutic strategies. Potential of four Cucurbitaceae seed lectins (CSLs) to inhibit SARS-CoV-2 attachment to host cells via interaction with receptor binding domain (RBD), was determined by Molecular Docking using PRODIGY and LZerD web servers. Among them, Luffa cylindrica lectin (PDB ID: 1NIO) displayed the most significant binding (B.E.: -24.9 kcal/mol; Kd: 0.052 aM). Further, docking (HADDOCK version 2.4) and interaction analysis (PDBsum and LigPlot+) of 1NIO with defined glycan site of SARS-CoV-2 spike protein revealed that glycans NAGs 1303, 1304, 1305, 1309 and 1314 on spike protein formed stable interactions with NAGs 248 and 249 on the lectin. Notably, NAG248 played a dual role in glycan-glycan interaction and binding. Momordia charantia seed lectin (MCSL) was partially purified using a combination of ethanol precipitation and affinity chromatography. Hemagglutination test confirmed antiviral activity and validated the utility of MCSL on human samples. Toxicity assessment of MCSL on normal HEK-293 cells using MTT assay revealed no significant effect on their morphology and viability at 10-100 µg/mL. Thus, CSLs have the potential to emerge as promising broad spectrum antiviral candidates against COVID-19 if investigated further. The present work is unique in that no such work is being done presently on anti-SARS-CoV-2 potential of CSLs. Also, very few in silico studies focusing on lectin-glycan interactions exist to date.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Spike Glycoprotein, CoronavirusSeedsPlant LectinsCucurbitaceaeAntiviral AgentsCOVID-19 Drug TreatmentLectinsHumansMolecular Docking SimulationCOVID-19PolysaccharidesProtein BindingBinding Sites

Stichwörter der Autor:innen

In Silico biologyAntiviral lectinsCucurbitaceae lectinsLectin-glycan interactionN-linked glycansPhytohemagglutininsSARS-CoV-2

Substanzen

Spike Glycoprotein, CoronavirusPlant Lectinsspike protein, SARS-CoV-2Antiviral AgentsPolysaccharidesLectins

Autor:innen und Institutionen

  • Dept. of Biochemistry, Era's Lucknow Medical College & Hospital, Era University, Sarfarazganj, Hardoi Road, Lucknow, 226003, UP, India. rumana_ahmad@yahoo.co.in.
  • Dept. of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, 226025, UP, India.
  • Dept. of Biotechnology, Era's Lucknow Medical College & Hospital, Era University, Sarfarazganj, Hardoi Road, Lucknow, 226003, UP, India.
  • Dept. of Biochemistry, Era's Lucknow Medical College & Hospital, Era University, Sarfarazganj, Hardoi Road, Lucknow, 226003, UP, India.
  • Department of Biochemistry, University of Lucknow, Lucknow, 226007, UP, India. anukusum@gmail.com.
  • Department of Internal Medicine, King George's Medical University, Lucknow, 226003, UP, India.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Ahmad, R., Akhter, Y., Varsha, Ahamad, T., Srivastava, A., Yadav, K., Siddiqui, S., Reddy, D. H., Gupta, A., Nigam, Y., Khan, M. A., Husain, I., Mishra, S., & Khan, M. A. (2025). In Silico and in vitro evaluation of Cucurbitaceae seed lectins as promising prophylactic and therapeutic agents against SARS-CoV-2. Glycoconjugate Journal. https://doi.org/10.1007/s10719-025-10196-9

Vancouver

Ahmad R, Akhter Y, Varsha, Ahamad T, Srivastava A, Yadav K, et al. In Silico and in vitro evaluation of Cucurbitaceae seed lectins as promising prophylactic and therapeutic agents against SARS-CoV-2. Glycoconjugate Journal. 2025. doi:10.1007/s10719-025-10196-9

BibTeX
@article{Ahmad2025,
  author = {Ahmad, Rumana and Akhter, Yusuf and Varsha and Ahamad, Tanveer and Srivastava, Aditi and Yadav, Kusum and Siddiqui, Sahabjada and Reddy, D Himanshu and Gupta, Ankita and Nigam, Yashi and Khan, Mohammad Amir and Husain, Ishrat and Mishra, Shivani and Khan, Mohsin Ali},
  title = {In Silico and in vitro evaluation of Cucurbitaceae seed lectins as promising prophylactic and therapeutic agents against SARS-CoV-2},
  journal = {Glycoconjugate Journal},
  year = {2025},
  doi = {10.1007/s10719-025-10196-9}
}
Kostenlos starten →